Thrombocytosis is either due to GOF alterations that activate MPL signaling (MPL, JAK2, CALR) or due to LOF mutations of negative regulators of this pathway (CBL, LNK) (Figure 1). This evidence concerns the gene JAK2 and Thrombocytosis.